PERKINS CAPITAL MANAGEMENT INC - Q1 2022 holdings

$122 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 110 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .

 Value Shares↓ Weighting
IDXX  IDEXX LABS INC$5,911,000
-16.9%
10,8050.0%4.85%
+0.9%
MSFT  MICROSOFT CORP$4,777,000
-8.3%
15,4930.0%3.92%
+11.3%
LLY  LILLY ELI & CO$3,840,000
+3.7%
13,4080.0%3.15%
+25.9%
ABT  ABBOTT LABS$3,205,000
-15.9%
27,0800.0%2.63%
+2.1%
LLNW  LIMELIGHT NETWORKS INC$2,378,000
+52.2%
455,5000.0%1.95%
+84.9%
OOMA  OOMA INC$2,255,000
-26.7%
150,4250.0%1.85%
-10.9%
CDNA  CAREDX INC$2,134,000
-18.7%
57,6920.0%1.75%
-1.2%
PFIE  PROFIRE ENERGY INC$2,025,000
+22.7%
1,557,9450.0%1.66%
+48.9%
LMAT  LEMAITRE VASCULAR INC$1,952,000
-7.5%
42,0000.0%1.60%
+12.4%
ABBV  ABBVIE INC$1,949,000
+19.7%
12,0250.0%1.60%
+45.4%
TGT  TARGET CORP$1,651,000
-8.3%
7,7790.0%1.35%
+11.4%
CSTL  CASTLE BIOSCIENCES INC$1,488,000
+4.6%
33,1700.0%1.22%
+27.1%
GIS  GENERAL MLS INC$1,446,000
+0.5%
21,3500.0%1.18%
+22.0%
AZYO  AZIYO BIOLOGICS INC$1,355,000
-5.6%
227,7290.0%1.11%
+14.7%
 ACHIEVE LIFE SCIENCES INC$1,322,000
-2.7%
174,6000.0%1.08%
+18.2%
SMED  SHARPS COMPLIANCE CORP$1,289,000
-17.3%
218,4550.0%1.06%
+0.5%
AUGX  AUGMEDIX INC$1,261,000
-6.7%
429,0000.0%1.03%
+13.4%
BMY  BRISTOL-MYERS SQUIBB CO$1,206,000
+17.2%
16,5080.0%0.99%
+42.3%
MRK  MERCK & CO INC$987,000
+7.0%
12,0250.0%0.81%
+30.1%
MMM  3M CO$954,000
-16.2%
6,4060.0%0.78%
+1.8%
GILD  GILEAD SCIENCES INC$937,000
-18.2%
15,7670.0%0.77%
-0.6%
AAPL  APPLE INC$864,000
-1.7%
4,9500.0%0.71%
+19.4%
 MDXHEALTH SAsponsored ads$747,000
-12.8%
90,0000.0%0.61%
+5.7%
PLUS  EPLUS INC$673,000
+4.0%
12,0000.0%0.55%
+26.3%
PRFT  PERFICIENT INC$628,000
-14.8%
5,7000.0%0.52%
+3.4%
OPCH  OPTION CARE HEALTH INC$605,000
+0.3%
21,2000.0%0.50%
+21.9%
FAST  FASTENAL CO$570,000
-7.3%
9,6000.0%0.47%
+12.5%
IFF  INTERNATIONAL FLAVORS&FRAGRA$563,000
-12.8%
4,2850.0%0.46%
+6.0%
CVS  CVS HEALTH CORP$542,000
-2.0%
5,3590.0%0.44%
+19.0%
DCI  DONALDSON INC$497,000
-12.3%
9,5670.0%0.41%
+6.3%
BLFS  BIOLIFE SOLUTIONS INC$477,000
-39.1%
21,0000.0%0.39%
-26.1%
USB  US BANCORP DEL$474,000
-5.4%
8,9170.0%0.39%
+15.1%
NXPI  NXP SEMICONDUCTOR N V$453,000
-18.8%
2,4500.0%0.37%
-1.6%
JNJ  JOHNSON & JOHNSON$408,000
+3.8%
2,3000.0%0.33%
+26.0%
CYRX  CRYOPORT INC$401,000
-41.0%
11,5000.0%0.33%
-28.3%
LFVN  LIFEVANTAGE CORPORATION$379,000
-24.7%
79,6130.0%0.31%
-8.5%
TCMD  TACTILE SYS TECHNOLOGY INC$342,000
+5.9%
16,9670.0%0.28%
+28.4%
LTRX  LANTRONIX INC$334,000
-14.8%
50,0000.0%0.27%
+3.4%
BAX  BAXTER INTL INC$311,000
-9.6%
4,0090.0%0.26%
+9.9%
MGNI  MAGNITE INC$311,000
-24.5%
23,5250.0%0.26%
-8.3%
MDT  MEDTRONIC PLC$288,000
+7.1%
2,6000.0%0.24%
+29.7%
BP  BP PLCspons adr$225,000
+10.3%
7,6500.0%0.18%
+33.3%
COST  COSTCO WHSL CORP NEW$219,000
+1.4%
3800.0%0.18%
+23.3%
INGN  INOGEN INC$217,000
-4.8%
6,7000.0%0.18%
+15.6%
ASUR  ASURE SOFTWARE INC$214,000
-24.1%
36,0000.0%0.18%
-7.9%
DGX  QUEST DIAGNOSTICS INC$202,000
-20.8%
1,4750.0%0.17%
-3.5%
DYAI  DYADIC INTL INC DEL$145,000
-33.2%
48,1000.0%0.12%
-18.5%
LUMN  LUMEN TECHNOLOGIES INC$143,000
-10.1%
12,7000.0%0.12%
+9.3%
CTEK  CYNERGISTEK INC$141,000
-6.6%
105,0000.0%0.12%
+13.7%
FBIO  FORTRESS BIOTECH INC$140,000
-45.5%
102,8050.0%0.12%
-33.5%
AIRG  AIRGAIN INC$117,000
-29.1%
15,5000.0%0.10%
-13.5%
VTRS  VIATRIS INC$115,000
-19.6%
10,5460.0%0.09%
-3.1%
 CREATIVE MED TECHNOLOGY HLDG$93,000
+78.8%
23,7500.0%0.08%
+117.1%
MIRO  MIROMATRIX MED INC$87,000
-15.5%
21,8800.0%0.07%
+1.4%
 BLUEJAY DIAGNOSTICS INC$25,000
-56.9%
22,5000.0%0.02%
-48.7%
 BRIGHT HEALTH GROUP INC$19,000
-44.1%
10,0000.0%0.02%
-30.4%
AIRI  AIR INDS GROUP$13,000
-13.3%
16,0000.0%0.01%
+10.0%
VERB  VERB TECHNOLOGY CO INC$11,000
-26.7%
12,0000.0%0.01%
-10.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-04-20
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NEOGENOMICS INC41Q3 20237.8%
LILY ELI & CO41Q3 20236.9%
PFIZER INC41Q3 20232.9%
ATTUNITY LTD41Q3 20233.6%
EXPEDITORS INTL WASH INC41Q3 20232.3%
CVS HEALTH CORP41Q3 20231.6%
DONALDSON INC41Q3 20231.3%
VERIZON COMMUNICATIONS INC41Q3 20231.0%
US BANCORP DEL41Q3 20230.8%
BAXTER INTL INC40Q3 202314.1%

View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.

Latest significant ownerships (13-D/G)
PERKINS CAPITAL MANAGEMENT INC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
BIOLASE, INCMay 15, 2023689,1962.1%
FlexShopper, Inc.February 09, 20231,281,4605.9%
Avinger IncFebruary 14, 2020891,7615.2%
Black Ridge Oil & Gas, Inc.February 15, 201930,021,0326.3%
CANCER GENETICS, INCFebruary 15, 20191,135,2504.0%
TearLab CorpFebruary 15, 20191,666,29413.1%
Xtant Medical Holdings, Inc.February 15, 2019684,4083.6%
TearLab CorpJanuary 26, 20184,300,65540.1%
BIO KEY INTERNATIONAL INCFebruary 09, 2017274,9004.4%
EnteroMedics IncFebruary 09, 20171,4550.0%

View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-01-22
13F-HR2023-11-02
13F-HR2023-07-21
SC 13G/A2023-05-15
13F-HR2023-05-09
SC 13G/A2023-02-09
SC 13G2023-02-09
13F-HR2023-01-26
13F-HR2022-10-24
13F-HR2022-07-29

View PERKINS CAPITAL MANAGEMENT INC's complete filings history.

Compare quarters

Export PERKINS CAPITAL MANAGEMENT INC's holdings